Retinal tears and detachments are common in PVD and VH patients

Article

Rate of retinal tears (RT) and detachments are higher in patients with an acute posterior vitreous detachment (PVD) and vitreous haemorrhage (VH) patients taking anticoagulants.

Rate of retinal tears (RT) and detachments are higher in patients with an acute posterior vitreous detachment (PVD) and vitreous haemorrhage (VH) patients taking anticoagulants, according to an investigation published in Eye.

Dr A. El-Sanjouri et al., Cincinnati Eye Institute, Cincinnati, Ohio, USA, studied 260 eyes of 260 patients presenting with an acute PVD and VH. All participants were divided into either those taking systemic anticoagulants and those not taking anticoagulants. Patients were examined for evidence of an RT and retinal detachment (RD). Out of the whole cohort, 137 took anticoagulants (Group 1) and 123 were not taking anticoagulants (Group 2).

In group 1 it was found that 46% of patients had an RT, compared to 72% in group 2. RDs were found in 23% of group 1 patients and 37% in group 2.

PVD and VH patients using anticoagulants experienced a higher rate of RTs and RDs than those who didn't take anticoagulants. The study suggests anticoagulation status could be a significant factor to consider for the occurrence of an RT or RD.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.